OTCMKTS:AOXG - Aoxing Pharmaceutical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.03 0.00 (0.00 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$0.03
Today's Range$0.03 - $0.03
52-Week Range$0.0001 - $0.0690
VolumeN/A
Average Volume6,938 shs
Market Capitalization$2.29 million
P/E RatioN/A
Dividend YieldN/A
Beta6.13
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China.

Receive AOXG News and Ratings via Email

Sign-up to receive the latest news and ratings for AOXG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:AOXG
Previous SymbolNYSEMKT:AXN
CUSIPN/A
CIKN/A
Phone86-311-8961-8579

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$32.33 million
Cash Flow$0.0476 per share

Profitability

Miscellaneous

Employees346
Market Cap$2.29 million
Next Earnings DateN/A
OptionableNot Optionable

Aoxing Pharmaceutical (OTCMKTS:AOXG) Frequently Asked Questions

What is Aoxing Pharmaceutical's stock symbol?

Aoxing Pharmaceutical trades on the OTCMKTS under the ticker symbol "AOXG."

How were Aoxing Pharmaceutical's earnings last quarter?

Aoxing Pharmaceutical Company Inc (OTCMKTS:AOXG) issued its quarterly earnings data on Monday, May, 16th. The company reported $0.01 earnings per share for the quarter. The business earned $6.56 million during the quarter. View Aoxing Pharmaceutical's Earnings History.

Has Aoxing Pharmaceutical been receiving favorable news coverage?

Press coverage about AOXG stock has trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Aoxing Pharmaceutical earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the stock's share price in the immediate future.

Who are some of Aoxing Pharmaceutical's key competitors?

What other stocks do shareholders of Aoxing Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aoxing Pharmaceutical investors own include Pernix Therapeutics (PTX), Agenus (AGEN), Spark Networks (LOV), Chesapeake Energy (CHK), CTI BioPharma (CTIC), Ballard Power Systems (BLDP), Ampio Pharmaceuticals (AMPE), AEterna Zentaris (AEZS), AcelRx Pharmaceuticals (ACRX) and Edap Tms (EDAP).

Who are Aoxing Pharmaceutical's key executives?

Aoxing Pharmaceutical's management team includes the folowing people:
  • Mr. Zhenjiang Yue, Chairman and Chief Exec. Officer (Age 60)
  • Mr. Guoan Zhang, CFO, Chief Accounting Officer & Sr. VP of Fin. (Age 49)
  • Ms. Yunlan Tang, Chief Engineer (Age 73)
  • Wei Zhang, Corp. Sec.
  • Ms. Guirong Zhou, Pres of R&D (Age 65)

How do I buy shares of Aoxing Pharmaceutical?

Shares of AOXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aoxing Pharmaceutical's stock price today?

One share of AOXG stock can currently be purchased for approximately $0.03.

How big of a company is Aoxing Pharmaceutical?

Aoxing Pharmaceutical has a market capitalization of $2.29 million and generates $32.33 million in revenue each year. Aoxing Pharmaceutical employs 346 workers across the globe.

What is Aoxing Pharmaceutical's official website?

The official website for Aoxing Pharmaceutical is axzyen.icm.cn.

How can I contact Aoxing Pharmaceutical?

Aoxing Pharmaceutical's mailing address is FLOOR 12 NO 2 BOJIN MANSION NO 8 GUANGAN STREET HEBEI PROVINCE, SHIJIAZHUANG CITY F4, 94404. The company can be reached via phone at 86-311-8961-8579 or via email at [email protected]


MarketBeat Community Rating for Aoxing Pharmaceutical (OTCMKTS AOXG)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  117
MarketBeat's community ratings are surveys of what our community members think about Aoxing Pharmaceutical and other stocks. Vote "Outperform" if you believe AOXG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AOXG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: Return on Investment (ROI)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel